Quick View
| Metric | Current Period | Same Period Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥681.2B | ¥640.6B | +6.3% |
| Operating Income | ¥41.7B | ¥38.6B | +8.2% |
| Ordinary Income | ¥48.0B | ¥42.3B | +13.3% |
| Net Income | ¥36.5B | ¥34.2B | +6.6% |
| ROE | 2.8% | 2.7% | - |
Executive Summary
For Q1 of the fiscal year ending December 2026, the Company recorded increases in both revenue and profit, with growth in ordinary income particularly pronounced. Revenue was ¥681.2B (+6.3% YoY), operating income was ¥41.7B (+8.2%), ordinary income was ¥48.0B (+13.3%), and net income was ¥36.5B (+6.6%). In addition to higher revenue, foreign exchange gains and equity-method investment income boosted ordinary income, resulting in growth exceeding that of operating income.
Factors Affecting Performance
【Revenue】Revenue was ¥681.2B, up +6.3% YoY. By segment, overseas businesses drove growth, with Printing Inks (Europe) up +19.1%, Functional Materials up +15.3%, and the Americas up +8.2%, while Japan was down -2.5% and Asia was limited to +2.0%. The expansion of the overseas inks business was the primary driver of revenue growth.
【Profit and Loss】Operating income was ¥41.7B (+8.2% YoY), and the operating margin improved from the previous year to 6.1%. Ordinary income was ¥48.0B (+13.3%), growing faster than operating income, supported by ¥1.7B in foreign exchange gains, ¥5.3B in equity-method investment income, and other operating non-income items generating a net gain. Net income was ¥36.5B (+6.6%). Extraordinary income and expenses consisted of ¥0.1B in gains on sales of investment securities and ¥0.1B in valuation losses and other items, resulting in an approximately neutral net impact. The gap between ordinary income and net income was primarily attributable to income taxes and other taxes (¥11.6B) and profit attributable to non-controlling interests (¥3.3B). Both revenue and profit increased, supporting the conclusion that the Company achieved higher revenue and higher profit.
Segment Analysis
Asia was the largest contributor to segment profit at ¥16.6B, with a profit margin of 11.6%, representing a +3.6% YoY increase in profit. The Americas had the largest revenue scale, with revenue of ¥276.6B (+8.2%), but profit declined to ¥12.9B (-16.9%), and the profit margin fell to 4.7%, resulting in higher revenue but lower profit. Europe recorded substantial profit growth, with revenue of ¥62.4B (+19.1%) and profit of ¥2.3B (+167.1%). Japan also achieved a significant improvement in profitability, with revenue of ¥121.8B (-2.5%) but profit of ¥5.6B (+105.8%). Functional Materials grew revenue to ¥75.2B (+15.3%), while profit of ¥6.1B (+0.2%) was virtually flat, and the profit margin declined from the previous year, making the conversion of revenue growth into profit a key challenge. The gap in profit margins between regions—Asia at 11.6% versus the Americas and Europe in the 4% range—is a focal point in assessing the sustainability of profitability improvements across the Company.
Key Financial Indicators
【Profitability】The operating margin improved from the same period of the previous year to 6.1%, while the net profit margin improved modestly to approximately 5.4%. ROE was 2.8% based on quarterly results; however, it is a cumulative quarterly figure and should not be compared directly with the full-year level.【Cash Flow Quality】Accounts receivable and notes receivable were ¥645.0B, representing 28.2% of total assets, indicating a somewhat high level of working capital tied up relative to the scale of revenue.【Investment Efficiency】Investment securities were ¥309.1B, representing 13.5% of total assets, a scale at which market fluctuations could affect net assets. Goodwill was small at ¥12.8B, limiting the risk of impairment related to M&A.【Financial Soundness】The equity ratio remained high at 56.1%, while current assets of ¥1285.8B substantially exceeded current liabilities of ¥633.9B. Although interest-bearing liabilities include ¥187.1B in long-term borrowings, the financial leverage structure remains conservative.
Cash Flow Analysis
As this report does not provide detailed disclosure of the cash flow statement, fund flows are analyzed based on changes in the balance sheet. Cash and deposits were ¥208.1B, virtually flat from ¥205.9B in the same period of the previous year, indicating that the cash position has remained stable. Meanwhile, accounts receivable and notes receivable increased to ¥645.0B from ¥625.3B in the previous year, indicating that the increase in revenue has resulted in a somewhat greater amount of working capital being tied up. Inventories were ¥193.5B, a slight decrease from ¥198.5B in the previous year, indicating progress in inventory adjustments. Short-term borrowings increased to ¥111.7B from ¥71.0B in the previous year, suggesting that rising working capital requirements may be being addressed through short-term financing. Overall, the Company appears to be compensating for increases in trade receivables during a period of revenue growth with higher short-term borrowings, making future trends in the collection of trade receivables a key determinant of the quality of cash management.
Earnings Quality
The difference between ordinary income and net income was primarily attributable to income taxes and other taxes (¥11.6B) and profit attributable to non-controlling interests (¥3.3B), while the impact of temporary factors was limited. Of operating non-income revenue of ¥9.1B, foreign exchange gains of ¥1.7B and equity-method investment income of ¥5.3B were the principal components. From the perspective of earnings repeatability, these items include a degree of reliance on external factors and are less stable than operating income. Extraordinary income and expenses consisted of ¥0.1B in gains on sales of investment securities and ¥0.1B in valuation losses and other items, resulting in an approximately zero net impact and only a minor effect on earnings quality. Comprehensive income was ¥53.6B, exceeding net income of ¥36.5B, primarily due to foreign currency translation adjustments of ¥13.0B. This divergence reflects accounting fluctuations arising from the yen conversion of overseas subsidiaries and should be distinguished from the Company’s underlying earning power.
Earnings Forecast and Guidance
The full-year Company forecasts are revenue of ¥2760.0B (+7.1% YoY), operating income of ¥170.0B (+11.6%), and ordinary income of ¥178.0B (+15.8%), with no revisions to the earnings forecasts. Q1 progress rates were 24.7% for revenue, 24.5% for operating income, and 26.9% for ordinary income, with no significant deviation from the standard quarterly progress rate of 25%. The slightly advanced progress rate for ordinary income reflects contributions from non-operating factors such as foreign exchange gains and equity-method investment income. The full-year plan assumes that operating income growth will exceed revenue growth, making the degree to which the planned improvement in profitability is achieved toward the second half of the fiscal year a key focus going forward.
Shareholder Returns
The Company’s full-year dividend forecast is ¥100.00 per share, with no revision to the dividend forecast. Based on forecast EPS of ¥241.84, the forecast payout ratio is approximately 41.4%, below the 60% level generally regarded as an indication of sustainability. Given the financial foundation, including an equity ratio of 56.1% and a current ratio exceeding 200%, constraints on maintaining the dividend appear limited at present.
Risk Factors
-
Deterioration in the profitability of the Americas segment: Printing Inks (Americas) has the largest revenue scale, with revenue of ¥276.6B (+8.2% YoY), but segment profit declined to ¥12.9B (-16.9%), and the profit margin fell to 4.7%. If the condition of higher revenue but lower profit persists, it could affect achievement of the full-year target of +11.6% operating income growth.
-
Divergence between revenue growth and profit growth in Functional Materials: Revenue increased to ¥75.2B (+15.3% YoY), while profit was virtually flat at ¥6.1B (+0.2%), and the profit margin is trending downward. The ability to pass through raw material costs and the product mix will be key areas of focus going forward.
-
Increasing trend in trade receivables: Accounts receivable and notes receivable increased to ¥645.0B from ¥625.3B in the previous year, representing 28.2% of total assets. The expansion of working capital accompanying revenue growth, together with the increase in short-term borrowings (¥71.0B in the previous year → ¥111.7B), requires monitoring from a cash management perspective.
Industry Benchmark (For Reference; Compiled by the Company)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 6.1% | 7.2% (3.2%–12.5%) | −1.1pt |
| Net Profit Margin | 5.4% | 5.9% (2.9%–12.5%) | −0.5pt |
Both the operating margin and net profit margin are slightly below the industry median, placing profitability in the middle to lower range within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 6.3% | 5.6% (1.1%–13.9%) | +0.7pt |
The revenue growth rate is slightly above the industry median, placing growth in the middle range within the industry.
※Source: Compiled by the Company
Key Takeaways from the Earnings Results
-
Q1 recorded increases in both revenue and profit, with progress rates against the full-year forecasts of 24.7% for revenue, 24.5% for operating income, and 26.9% for ordinary income, indicating performance broadly in line with the plan.
-
By region, the Americas recorded higher revenue but lower profit, while Functional Materials recorded higher revenue with virtually flat profit, and the structure of reliance on Asia’s high profitability continues. Profitability improvements in the Americas and Functional Materials are important variables for achieving the full-year plan.
-
Trade receivables and short-term borrowings are increasing simultaneously, making the management of working capital during the period of revenue growth a key point to monitor in future earnings results.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear (bearish) | ¥2,579 |
| base (base case) | ¥2,642 |
| bull (bullish) | ¥2,693 |
| Calculation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥2,635 |
| Adjusted Forecast EPS | ¥260.0 |
| Cost of Equity r | 9.77% (10-year government bond 2.77% + equity risk premium 6.00% + size premium 1.00%) |
| Persistence Factor of Residual Income ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 41.3% |
| Forecast EPS Confidence Adjustment | ×1.075 (based on the peer-industry track record of achieving guidance) |
| Implied PBR / PER | 1.00x / 10.2x |
Sensitivity: ¥2,570–¥2,718 at cost of equity ±1%, and ¥2,642–¥2,642 at ω±0.1.
Notes:
- Net assets as of the end of the quarter are used (there is a time lag relative to the full-year forecast).
- As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.
(Calculation model: Residual Income Model (Ohlson type, explicit 5-year fade) / Interest-rate reference month: 2026-07 / Mechanically calculated value based solely on publicly available data; it does not forecast market share prices or recommend any specific investment action, and does not predict or guarantee future share prices.)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.
---End of Report---
AI Financial Analysis
Executive Summary
Sakata Inx delivered a solid FY2026 Q1 result, with revenue growth translating into modest operating-margin expansion and faster ordinary-income growth. Revenue increased 6.3% year on year to ¥68.12bn. Operating income rose 8.2% to ¥4.17bn. Ordinary income grew 13.3% to ¥4.80bn, outpacing operating income. Profit attributable to owners of parent increased 7.7% to ¥3.31bn. Gross profit expanded 9.5% to ¥17.31bn, faster than revenue growth. The gross margin improved by approximately 73bp year on year to 25.4%. The operating margin improved by approximately 10bp to 6.1%, as the gross-margin gain was partly absorbed by SG&A expenses, which increased 10.0% to ¥13.13bn. Net margin was broadly stable to slightly higher at 4.9%, up around 6bp year on year. Non-operating income increased to ¥0.91bn, supported by ¥0.53bn of equity-method earnings and ¥0.17bn of foreign-exchange gains. Interest expense declined to ¥0.22bn from ¥0.24bn, supporting the increase in ordinary income. A small ¥0.14bn gain on sales of investment securities lifted pre-tax income only marginally and does not materially alter the recurring earnings assessment. Comprehensive income was ¥5.37bn, above profit attributable to owners, reflecting positive translation and equity-method OCI effects. The Americas remained the largest revenue region at ¥27.47bn, while Asian printing inks generated the largest segment-profit contribution at ¥1.66bn. Japan and Europe delivered the strongest segment-profit growth, whereas the Americas saw a decline in segment profit despite revenue expansion. The full-year plan was maintained, and Q1 progress is broadly consistent with the annual targets. The principal operating issue to monitor is the elevated annualized receivable collection period of 86 days, which raises working-capital intensity and cash-conversion risk.
Profitability Analysis
Annualized DuPont ROE is 10.3%, comprising a 4.9% net profit margin, 1.190x asset turnover, and 1.78x financial leverage. This places ROE within the 10-15% range generally regarded as good, but the return profile is driven more by reasonable asset utilization and leverage than by a high net margin. The 6.1% EBIT margin is the main profitability constraint relative to higher-margin industrial benchmarks, although it improved slightly year on year. Gross margin improved to 25.4% from approximately 24.7% in the prior-year quarter, a 73bp expansion, indicating favorable sales mix, pricing, procurement, or manufacturing-cost absorption. Operating-margin expansion was limited to roughly 10bp because SG&A rose 10.0%, faster than the 6.3% increase in revenue. This differential bears monitoring, although the higher gross profit more than covered the additional overhead in Q1. The annualized asset-turnover component of 1.190x is healthy for a global ink and materials manufacturer with a meaningful production and distribution asset base. Financial leverage of 1.78x is moderate and does not indicate an aggressive capital structure. The five-factor analysis shows a tax burden of 0.690, close to normal, and an interest burden of 1.151 because non-operating income more than offset interest expense; the latter should not be interpreted as solely a debt-service benefit. Interest coverage of 19.05x is strong. Segment profitability was led by Printing Inks Asia, which earned ¥1.66bn, making it the core business by operating-income contribution. Asia's segment margin was 11.6%, broadly stable from 11.5% a year earlier. Japan's segment profit more than doubled to ¥0.56bn and margin rose to 4.7% from 2.2%. Europe improved materially, with segment profit increasing to ¥0.23bn from ¥0.09bn and margin improving to 3.7% from 1.7%. In contrast, the Americas' segment margin fell to 4.7% from 6.1%, with segment profit declining 16.9% despite 8.3% revenue growth.
Growth Assessment
Revenue growth was broad-based outside Japan and the smaller other-business category. Printing Inks Americas, the largest revenue segment, grew 8.3% year on year to ¥27.47bn. Printing Inks Asia increased 2.2% to ¥14.28bn. Printing Inks Europe increased 19.8% to ¥6.06bn. Functional Materials grew 15.0% to ¥7.50bn, making it an important incremental growth contributor. Japan printing inks and equipment declined 2.5% in revenue to ¥11.94bn, although its substantial profit improvement indicates better profitability rather than a demand-led acceleration. The other-business category declined 2.8% in revenue to ¥0.88bn and segment profit fell 57.0% to ¥0.05bn. Consolidated operating-income growth of 8.2% exceeded revenue growth, demonstrating positive operating leverage at the group level despite SG&A growth exceeding sales growth. Ordinary income growth of 13.3% also benefited from stronger equity-method income, which increased to ¥0.53bn from ¥0.35bn. Full-year revenue guidance is ¥276.0bn, implying Q1 progress of 24.7% against a standard 25% first-quarter run rate. Operating-income progress is 24.5% against the ¥17.0bn full-year target, also close to the standard pace. Ordinary-income progress is 26.9% against the ¥17.8bn target, modestly ahead of a standard Q1 run rate. Profit attributable to owners has reached 28.1% of the ¥11.8bn annual target, moderately ahead of the standard 25% pace. Management has not revised its full-year guidance, indicating that the Q1 outperformance has not yet been treated as a basis for a forecast upgrade. Sustained recovery in Japan and Europe, together with stabilization of Americas margins, would be important for converting revenue growth into a more meaningful full-year earnings upside.
Financial Health
Liquidity is strong, with a current ratio of 202.8% and a quick ratio of 172.3%. Current assets of ¥128.58bn exceed current liabilities of ¥63.39bn by ¥65.19bn. Cash and deposits total ¥20.81bn, equivalent to 1.86x short-term loans of ¥11.17bn. This supports short-term refinancing flexibility even with the increase in short-term borrowing. Interest-bearing debt is ¥29.89bn, and the debt-to-equity ratio of 0.78x remains conservative relative to the 1.0x benchmark. Debt/capital is 18.9%, well below the 40% investment-grade reference threshold. Long-term loans of ¥18.71bn exceed short-term loans, and only 37.4% of debt is classified as short term, limiting maturity-mismatch risk. Lease obligations total ¥3.89bn, comprising ¥0.96bn current and ¥2.93bn non-current obligations, and are manageable relative to equity and liquidity. The material balance-sheet change is short-term loans, which increased 57.4% year on year, or ¥4.08bn, to ¥11.17bn. This appears partly associated with working-capital financing: trade receivables increased ¥1.98bn year on year while electronically recorded operating obligations decreased ¥5.17bn. The substitution of electronic payables with short-term loans increases direct funding dependence, although the current liquidity position and interest coverage mitigate immediate stress. Total equity increased to ¥128.42bn, and the equity ratio remained stable at 52.7%. Goodwill is only 1.0% of equity and 0.6% of assets, so the balance sheet has minimal dependence on acquisition-value retention. Investment securities are ¥30.91bn, or 13.5% of total assets, providing potential balance-sheet value but also exposing comprehensive income and equity to market-price movements. Asset retirement obligations are ¥0.75bn, immaterial relative to total liabilities.
Notable B/S Changes
Short-term loans: +¥4.08bn (+57.4%) to ¥11.17bn — a significant increase in short-term funding. Strong cash coverage and liquidity limit immediate refinancing risk, but the movement should be assessed alongside the 86-day receivable cycle and the reduction in electronically recorded operating obligations.
Cash Flow Quality
Dividend Sustainability
The full-year dividend forecast is ¥100 per share. Against forecast EPS of ¥241.84, the implied dividend payout ratio is approximately 41.3%. This is below the 60% sustainability benchmark and leaves capacity for retained earnings, debt service, capital investment, and working-capital funding. Q1 EPS was ¥67.65, representing 28.0% of forecast EPS, broadly consistent with the 28.1% progress rate for profit attributable to owners. Retained earnings of ¥924.42bn provide a substantial accounting equity buffer relative to the planned shareholder distribution. The unchanged dividend forecast alongside unchanged earnings guidance suggests management currently views the planned distribution as compatible with its operating and financial framework. The elevated receivable collection cycle should remain a focus in assessing the cash backing of future distributions.
Risk Assessment
Business risks include Americas profitability risk: Americas revenue rose 8.3% to ¥27.47bn, but segment profit declined 16.9% to ¥1.29bn and margin compressed by about 142bp to 4.7%. As the largest revenue segment, further margin pressure would have a material group impact., Working-capital and customer-credit risk: annualized DSO is 86 days, above the 60-day warning threshold. Slow collection increases funding needs, raises exposure to customer-payment delays, and can weaken conversion of reported earnings into operating cash generation., Input-cost and energy-cost risk: as an ink and functional-materials manufacturer, earnings remain exposed to petrochemical derivatives, pigments, resins, solvents, packaging, and energy costs. The Q1 gross-margin improvement should be tested for durability against raw-material volatility., Foreign-exchange and overseas-execution risk: overseas operations account for the majority of segment revenue, and Q1 ordinary income included ¥0.17bn of FX gains. Currency moves can affect translated sales, local cost competitiveness, and non-operating profit., Functional-materials demand and technology risk: Functional Materials grew 15.0% to ¥7.50bn, but its 8.1% segment margin was below the prior-year 9.3%. Maintaining growth while protecting margin requires product differentiation and disciplined commercialization..
Financial risks include Short-term borrowing increased 57.4% year on year to ¥11.17bn. The increase is manageable given cash coverage of 1.86x and a 202.8% current ratio, but it increases sensitivity to funding conditions and working-capital swings., Investment securities of ¥30.91bn represent 13.5% of total assets. Changes in equity-market valuations may affect other comprehensive income and reported equity., Interest-bearing debt of ¥29.89bn is manageable at a 0.78x debt-to-equity ratio and 19.05x interest coverage, but debt-funded working-capital requirements could rise if receivable collection remains extended..
Key concerns include Priority 1 — receivable collection: DSO of 86 days is the most explicit earnings-quality and liquidity concern because it can absorb cash even while reported profit grows., Priority 2 — Americas margin recovery: the region is the largest sales contributor, and its profit decline offsets gains in Japan and Europe., Priority 3 — SG&A discipline: SG&A increased 10.0%, faster than sales growth of 6.3%; sustained excess cost growth could prevent gross-margin gains from reaching operating profit., Priority 4 — financing mix: the rise in short-term loans alongside lower electronic payables should be monitored for evidence of a structural rather than temporary increase in working-capital funding needs..
Investment Implications
Key takeaways include Q1 showed a favorable combination of 6.3% sales growth, 8.2% operating-income growth, and a 73bp gross-margin expansion., Annualized ROE of 10.3% is supported by a 4.9% net margin, 1.190x asset turnover, and moderate 1.78x financial leverage., Printing Inks Asia is the core business by segment-profit contribution, while the Americas remains the principal sales engine and the key margin risk., Japan and Europe showed substantial segment-profit recovery, improving the geographic balance of group earnings., Liquidity, leverage, and interest coverage remain sound, while the rise in short-term loans warrants monitoring in conjunction with receivables., The implied 41.3% forecast dividend payout ratio appears moderate relative to forecast earnings..
Metrics to watch include Americas segment margin and segment profit trend, Annualized DSO, trade receivables, and the relationship between receivables and short-term borrowings, Gross-margin retention amid raw-material, energy, and foreign-exchange movements, SG&A growth relative to revenue growth, Functional Materials revenue growth and margin, Progress versus full-year operating-income guidance of ¥17.0bn, Equity-method earnings contribution and foreign-exchange gains/losses, Investment-security valuation effects on other comprehensive income and equity.
Regarding relative positioning, The company presents a balanced financial profile for a global specialty-chemical and printing-ink manufacturer: profitability is improving but remains mid-range at a 6.1% operating margin; annualized ROE is solid at 10.3%; leverage is moderate; and liquidity is strong. Its differentiating strengths are diversified regional earnings and low goodwill dependence, while relative constraints are extended customer collection periods and margin weakness in the large Americas business.